Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Viewpoint
  • Published:

Personalized genomic information: preparing for the future of genetic medicine

Abstract

The falling cost of sequencing means that we are rapidly approaching an era in which access to personalized genomic information is likely to be widespread. Here, four experts with different insights into the field of genomic medicine answer questions about the prospects for using this type of information. Their responses highlight the diverse range of issues that must be addressed — ranging from scientific to ethical and logistical — to ensure that the potential benefits of personal genomic information outweigh the costs to both individuals and societies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Fernhoff, P. M. Newborn screening for genetic disorders. Pediatr. Clin. North Am. 56, 505–513 (2009).

    Article  PubMed  Google Scholar 

  2. Feero, W. G., Guttmacher, A. E. & Collins, F. S. The genome gets personal — almost. JAMA 299, 1351–1352 (2008).

    Article  CAS  PubMed  Google Scholar 

  3. Check Hayden, E. Genome sequencing: the third generation. Nature. 457, 768–769 (2009).

    Article  PubMed  Google Scholar 

  4. Deyo, R. A. Cascade effects of medical technology. Ann. Rev. Public Health. 23, 23–44 (2002).

    Article  Google Scholar 

  5. McGuire, A. L. & Burke, W. An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons. JAMA 300, 2669–2671 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. International Warfarin Pharmacogenetics Consortium. Estimation of the warfarin dose with clinical and pharmacogenetic data. N. Engl. J. Med. 360, 753–764 (2009).

  7. Pharoah, P. D. P. et al. Polygenes, risk prevention, and targeted prevention of breast cancer. N. Engl. J. Med. 358, 2796–2803 (2008).

    Article  CAS  PubMed  Google Scholar 

  8. Goldstein, D. B., Common genetic variation and human traits. N. Engl. J. Med. 360, 1696–1698 (2009).

    Article  CAS  PubMed  Google Scholar 

  9. Helgadottir, A. et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316, 1491–1493 (2007).

    Article  CAS  PubMed  Google Scholar 

  10. McPherson, R. et al. A common allele on chromosome 9 associated with coronary heart disease. Science 316, 1488–1491 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Gudbjartsson, D. F. et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nature Genet. 41, 342–347 (2009).

    Article  CAS  PubMed  Google Scholar 

  12. Erdmann, J. et al. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nature Genet. 41, 280–282 (2009).

    Article  CAS  PubMed  Google Scholar 

  13. Samani, N. J. et al. Genomewide association analysis of coronary artery disease. N. Engl. J. Med. 357, 443–453 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Myocardial Infarction Genetics Consortium. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nature Genet. 41, 334–341 (2009).

  15. United States Government Accountability Office. Nutrigenetic Testing: Tests Purchased from Four Web Sites Mislead Consumers [online], (2006).

  16. Federal Trade Commission. At-Home Genetic Tests: A Healthy Dose of Skepticism May Be the Best Prescription [online], (2009).

  17. Klein, R. J. et al. Complement factor H polymorphism in age-related macular degeneration. Science. 308, 385–389 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Moshfeghi, D. M. & Blumenkranz, M. S. Role of genetic factors and inflammation in age-related macular degeneration. Retina 27, 269–275 (2007).

    Article  PubMed  Google Scholar 

  19. Mendoza, O. Patient-centered healthcare. Nature Biotech. 17, BV15 (1999).

    Article  Google Scholar 

  20. Stolberg, S. G. A small leap to designer babies. New York Times E7 (1 Jan 2000).

  21. Xu, J. et al. Estimation of absolute risk for prostate cancer using genetic markers and family history. Prostate 69, 1565–1572 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Flockhart, D. A., Skaar, T., Berlin, D. S., Klein, T. E. & Nguyen, A. T. Clinically available pharmacogenomics tests. Clin. Pharmacol. Ther. 86, 109–113 (2009).

    Article  CAS  PubMed  Google Scholar 

  23. Zheng, S. L. et al. Two independent prostate cancer risk-associated loci at 11q13. Cancer Epidemiol. Biomarkers Prev. 18, 1815–1820 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Lazarou, J., Pomeranz, B. H. & Corey, P. N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279, 1200–1205 (1998).

    Article  CAS  PubMed  Google Scholar 

  25. Belmont, J. & McGuire, A. L. The futility of genomic counseling: essential role of electronic health records. Genome Med. 1, 48 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  26. Bodmer, W. & Bonilla, C. Common and rare variants in multifactorial susceptibility to common diseases. Nature Genet. 40, 695–701 (2008).

    Article  CAS  PubMed  Google Scholar 

  27. Schadt, E. E., Friend, S. H. & Shaywitz, D. A. A network view of disease and compound screening. Nature Rev. Drug Discov. 8, 286–295 (2009).

    Article  CAS  Google Scholar 

  28. Guttmacher, A. E., Porteous, M. E. & McInerney, J. D. Educating health care professionals about genetics and genomics. Nature Rev. Genet. 8, 151–157 (2007).

    Article  CAS  PubMed  Google Scholar 

  29. Lanie, A. D. et al. Exploring the public understanding of basic genetic concepts. J. Genet. Couns. 13, 305–320 (2004).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

Kári Stefánsson is an employee of and shareholder in deCODE genetics.

Related links

Related links

FURTHER INFORMATION

Alan E. Guttmacher's homepage

Amy L. McGuire's homepage

Bruce Ponder's homepage

Kári Stefánsson's homepage

23andMe

National Human Genome Research Institute Catalog of Published Genome-Wide Association Studies

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guttmacher, A., McGuire, A., Ponder, B. et al. Personalized genomic information: preparing for the future of genetic medicine. Nat Rev Genet 11, 161–165 (2010). https://doi.org/10.1038/nrg2735

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrg2735

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing